Phenyltriazolinones as potent factor Xa inhibitors
Authors:
- 1 February 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (4) , 1373-1377
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in DevelopmentClinical Pharmacokinetics, 2009
- Brave new world: The current and future use of novel anticoagulantsThrombosis Research, 2008
- Will Warfarin Soon Be Passé? New Approaches to Stroke Prevention in Atrial FibrillationJournal of Cardiovascular Pharmacology, 2008
- Rivaroxaban, an oral direct factor Xa inhibitorExpert Opinion on Investigational Drugs, 2008
- New oral Xa and IIa inhibitors: updates on clinical trial resultsJournal of Thrombosis and Thrombolysis, 2007
- Rationale for the use of antifactor Xa in the treatment and prevention of venous and arterial thromboembolic eventsEuropean Journal of Clinical Investigation, 2005
- New anticoagulantsBlood, 2005
- The Dynamics of Thrombin FormationArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Coagulation Factor Xa Inhibition: Biological Background and RationaleCurrent Topics in Medicinal Chemistry, 2001
- Synthetic Inhibitors of Thrombin and Factor XaThrombosis Research, 1999